Success Stories: We Helped a Staff Scientist in the Field of Molecular Pharmacology Secure EB-1A and NIW Approval Without RFE
Client’s Testimonial:
"It’s a long process of preparing all kinds of documents. The lawyers are so patient, responsible and professional. They replied my questions in time and explained everything in detail. I’m so glad I chose WeGreened to take care of my case.”
On March 31st, 2020 and April 14th, 2020, we received another EB-1A (Alien of Extraordinary Ability) and NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Molecular Pharmacology (Approval Notice).
General Field: Molecular Pharmacology
Position at the Time of Case Filing: Staff Scientist
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: March 31st, 2020 (EB-1A) and April 14th, 2020 (NIW)
Processing Time: 3 months, 18 days (EB-1A) and 5 months, 14 days (NIW)
Case Summary:
A noted staff scientist from China hired North America Immigration Law Group (WeGreened.com) to represent her in two I-140 cases- an EB-1A (Alien of Extraordinary Ability) and an EB-2 NIW (National Interest Waiver). Many of our clients ask us to file these two petitions together because it significantly increases their chances of obtaining an approval, and also because these visa categories are quite similar, in that they have a few overlapping eligibility requirements. The following points were stated in both the petitions:
- Research Details: Our client’s research on cancer therapy has the potential to significantly benefit the field of molecular pharmacology. Her research in this area is of great importance because it has major bearing on the development of advanced treatments for a number of major diseases, including Cushing’s disease, colorectal cancer, and HIV.
- Publication Record & Citations: The findings from her various research projects has been published in 14 peer-reviewed journal articles (8 of them first- and co-first-authored) and has helped other researchers from all around the world who are pursuing research in similar fields. With the help of Google Scholar we concluded that our client’s work had been cited 464 times by her peers.
- Review Work: Another piece of information that overlapped in both the petitions was the number of times she had assessed the work of other experts in the scientific community. Our client, who is a regular reviewer for leading journals in the field of molecular pharmacology, had conducted 130 reviews at the time of filing the petitions.
All of the above evidence was corroborated by the inclusion of 4 recommendation letters written by renowned figures in the field. They urged the USCIS to grant our client the approval so that she can continue her research in the United States. One such recommender stated:
“[Client’s] repeated successes in the field of molecular medicine function as hard evidence that she will continue to hold a dominant presence in the field. Her leadership cannot be overstated, and research has been of tremendous benefit to society as a whole. Thus, it is clearly in the interest of the United States to wholeheartedly support the continuation of her research efforts.”
We are extremely pleased that our diligent efforts led to not one, but two, petition approvals. We congratulate our client for getting one step closer to her green card and we wish her the best as she continues to conduct important research in the field of molecular pharmacology.